CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
AFT Pharmaceuticals Ltd Company Snapshot
AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The Company's NasoSURF Nebuliser is in pilot scale production. The Company is focused on conducting clinical for Maxigesic oral dose forms. The Company is also conducting clinical trials of Maxigesic intravenous (IV). Maxigesic PE is a cold and flu variant. Its subsidiary, AFT Pharmaceuticals (AU) Pty Ltd, is engaged in distribution of pharmaceuticals in Australia. Its subsidiary, AFT Pharmaceuticals Singapore Pte Ltd, is engaged in the registration of pharmaceuticals in Singapore. Its subsidiary, AFT Pharmaceuticals (S.E. Asia) Sdn Bhd, is engaged in the distribution of pharmaceuticals in Malaysia.

Sales Analysis. AFT Pharmaceuticals Ltd reported sales of 105.60 million New Zealand Dollars (US$69.43 million) for the fiscal year ending March of 2020. This represents an increase of 24.0% versus 2019, when the company's sales were 85.13 million New Zealand Dollars. Sales at AFT Pharmaceuticals Ltd have increased during each of the previous five years (and since 2015, sales have increased a total of 88%). Sales of Southeast Asia saw an increase that was more than double the company's growth rate: sales were up 130.2% in 2020, from 2.14 million New Zealand Dollars to 4.93 million New Zealand Dollars. AFT Pharmaceuticals Ltd also saw significant increases in sales in Rest of World (up 55.2% to 9.13 million New Zealand Dollars) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
AFT Pharmaceuticals Ltd
  Stock Performance Chart for AFT Pharmaceuticals Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (7/10/2020): 4.22
(Figures in New Zealand Dollars)
1 Week 1.9%   13 Weeks 9.6%  
4 Weeks -8.1%   52 Weeks 32.3%  
 
AFT Pharmaceuticals Ltd Key Data:
  Ticker: AFT Country: New Zealand
  Exchanges: NZL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 105,597,000
(Year Ending Jan 2021).
Employees: 86
  Currency: New Zealand Dollars Market Cap: 424,696,660
  Fiscal Yr Ends: March Shares Outstanding: 100,639,019
  Share Type: Ordinary Closely Held Shares: 90,306,652
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.